当前位置： SCI文献检索 > Brachytherapy期刊下所有文献 > Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.

Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.

Abstract：

PURPOSE:Although surgery remains a treatment option for symptomatic brain metastases, the need for adjuvant radiation after surgery is widely accepted as standard. Despite a multitude of randomized trials aimed at identifying the ideal radiation treatment plan for surgically resected metastases, the development of new delivery regiments necessitates a periodic re-evaluation of dosimetric performance/outcome. Here, we compare the homogeneity index (HI) across three platforms: single-session stereotactic radiosurgery (SRS), multisession stereotactic radiotherapy, and intraoperative radiotherapy (IORT). METHODS AND MATERIALS:Patients treated with IORT after surgical resection of brain metastases were identified and dosimetric parameters collected from the dose-volume histograms based on the development of conformal plans for adjuvant radiation using Gamma Knife-SRS (GK-SRS), linear accelerator based intensity-modulated radiation therapy, and IORT. HIs were calculated using four established methods and compared across platforms within the patient cohort. Statistical analyses were performed using analysis of variance. RESULTS:The mean maximal doses for the GK-SRS and IMRT plans were 30 Gy and 29 Gy with margin prescription doses of 16 Gy and 24 Gy, respectively. The IORT dose was 30 Gy to the applicator surface. HIs varied based on calculation methods, but maintained consistency when comparing across platforms with IORT having the lower mean HI value (0.56; 95% confidence interval (CI) 0.55-0.60) in single-fraction treatment, compared with GK-SRS (0.77; 95% CI 0.76-0.80). The mean multisession IMRT HI was lower than both single-fraction treatment modalities at 0.41 (95% CI 0.40-0.42). CONCLUSIONS:When using the HI as the primary dosimetric parameter for adjuvant radiation plans after surgical resection of brain metastases IORT offers improved dose homogeneity compared with GK-SRS in single-fraction treatment, whereas fractionated LINAC-based IMRT was superior with respect to the HI in comparison among all three methods.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Dahshan BA,Weir JS,Bice RP,Renz P,Cifarelli DT,Poplawski L,Hack J,Vargo JA,Cifarelli CP

doi

10.1016/j.brachy.2020.11.004

subject

Has Abstract

pub_date

2021-01-13 00:00:00

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(20)30248-8

pub_type

杂志文章

相关文献

Brachytherapy文献大全
  • High-dose-rate interstitial brachytherapy in oral cancer-Its impact on quality of life.

    abstract：PURPOSE:The aim of the study was to assess the impact of high-dose-rate (HDR) interstitial brachytherapy on quality of life (QOL) in oral cancer. METHODS AND MATERIALS:Thirty-two patients of oral cancer treated at our institute from January 2010 to December 2014 with radical radiotherapy (external beam radiotherapy + ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.02.002

    authors： Bajwa HK,Singareddy R,Alluri KR

    更新日期：2016-05-01 00:00:00

  • Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy.

    abstract：PURPOSE:To identify patients at extremely low risk of biochemical recurrence (BCR) of prostate cancer after low-dose-rate brachytherapy (LDR-BT) to determine when prostate-specific antigen (PSA) monitoring can be stopped. METHODS AND MATERIALS:We retrospectively reviewed clinicopathologic data of patients with prostat...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2018.08.018

    authors： Niwa N,Matsumoto K,Nishiyama T,Yagi Y,Ozu C,Nakamura K,Saito S,Oya M

    更新日期：2018-01-01 00:00:00

  • Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer.

    abstract：BACKGROUND:To determine the feasibility of combined perioperative high-dose-rate brachytherapy (PHDRB) and intermediate-dose external beam radiation therapy (EBRT) as an alternative to full-dose adjuvant EBRT in patients with unirradiated squamous cell cancer (SCC) of the oral cavity and oropharynx. METHODS AND MATERI...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.10.002

    authors： Martínez-Monge R,Gómez-Iturriaga A,Cambeiro M,Garrán C,Montesdeoca N,Aristu JJ,Alcalde J

    更新日期：2009-01-01 00:00:00

  • Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning.

    abstract：PURPOSE:Low-dose-rate brachytherapy using iodine-125 seeds is a highly efficacious treatment for low-risk prostate cancer. We propose a bioeffect model may be used to target an ablative dose to the tumor with a lower, therapeutic dose to low-risk regions to maintain high rates of tumor control with reduced toxicity. We...

    journal_title：Brachytherapy

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.brachy.2013.04.008

    authors： Haworth A,Williams S,Reynolds H,Waterhouse D,Duchesne GM,Bucci J,Joseph D,Bydder S,Ebert M

    更新日期：2013-11-01 00:00:00

  • Feasibility and full-course dosimetry of an intraoperatively placed multichannel brachytherapy catheter for accelerated partial breast irradiation.

    abstract：PURPOSE:Determine feasibility and resultant dosimetry of an intraoperatively placed multichannel intracavitary brachytherapy catheter for accelerated partial breast irradiation (APBI). METHODS:Patients with breast cancer underwent intraoperative brachytherapy catheter placement based on frozen section analysis with im...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.08.002

    authors： Stish BJ,Pafundi DH,Hieken TJ,Whitaker TJ,Furutani KM,Jakub JW,Boughey JC,Degnim AC,McLemore LB,Mou B,Mutter RW,Park SS

    更新日期：2016-01-01 00:00:00

  • Postmortem radiation safety and issues pertaining to permanent prostate seed implantation in Japan.

    abstract：PURPOSE:If a prostate cancer patient treated with (125)I brachytherapy dies within 12 months after the treatment, prostate removal before cremation is recommended to avoid problems related to radioactivity in the ashes, such as inhalation of airborne particulate matter by crematorium staff or nearby residents. To provi...

    journal_title：Brachytherapy

    pub_type： 杂志文章,评审

    doi：10.1016/j.brachy.2014.08.043

    authors： Satoh T,Dokiya T,Yamanaka H,Saito S,Ishiyama H,Itami J,Shibuya H,Nakano T,Shigematsu N,Aoki M,Egawa S,Hashimoto M,Nishimura T,Yorozu A

    更新日期：2015-03-01 00:00:00

  • Radiation protection and dosimetry issues for patients with prostate cancer after I-125 low-dose-rate brachytherapy permanent implant.

    abstract：PURPOSE:The aim of this work was to analyze the exposure rates measured in the proximity of patients who underwent prostate low-dose-rate brachytherapy with I-125 implant. Effective doses to relatives and to population were computed to estimate the time to reach radioprotection dose constraints. METHODS AND MATERIALS:...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.09.003

    authors： Licciardello T,Feliciani G,Mazzotti G,Mostacci D,Sarnelli A,Menghi E

    更新日期：2021-01-01 00:00:00

  • Novel and programmatic improvements to the workflow associated with the AccuBoost breast brachytherapy procedure.

    abstract：PURPOSE:While the noninvasive breast brachytherapy (NIBB) treatment procedure, known as AccuBoost, for breast cancer patients is well established, the treatment quality can be improved by the efficiency of the workflow delivery. A formalized approach evaluated the current workflow through failure modes and effects anal...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.01.007

    authors： Roles SA,Hepel JT,Leonard KL,Wazer DE,Cardarelli GA,Schwer ML,Saleh ZH,Klein EE,Brindle JM,Rivard MJ

    更新日期：2020-01-01 00:00:00

  • Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.

    abstract：PURPOSE:Dose escalation has been shown beneficial in prostate cancer. Brachytherapy (BT) provides an opportunity for dose escalation beyond what can be safely delivered using only teletherapy methods. The purpose of this study was to determine cancer control and morbidity of external beam radiation therapy (EBRT) plus ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2009.01.002

    authors： Koontz BF,Chino J,Lee WR,Hahn CA,Buckley N,Huang S,Kim J,Reagan R,Joyner R,Anscher MS

    更新日期：2009-04-01 00:00:00

  • High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay.

    abstract：PURPOSE:This work quantifies the influence of intrafraction DNA damage repair and cellular repopulation on biologically effective dose (BED) in Ir-192 high-dose-rate brachytherapy for prostate cancer. In addition, it examines the effect of source-decay-induced BED variation for patients treated at different time points...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.04.005

    authors： Tien CJ,Carlson DJ,Nath R,Chen ZJ

    更新日期：2019-01-01 00:00:00

  • Clinical implementation of a novel Double-Balloon single-entry breast brachytherapy applicator.

    abstract：PURPOSE:The purpose of the study was to describe the clinical utilization of a novel Double-Balloon applicator for accelerated partial breast irradiation (APBI). METHODS AND MATERIALS:The Double-Balloon single-entry breast applicator contains a single central treatment catheter, as well as four peripheral catheters th...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.07.015

    authors： Anderson BM,Wallace CR,De Costa AA,Das RK

    更新日期：2017-01-01 00:00:00

  • Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.

    abstract：PURPOSE:In 2012, our institution transitioned from low-dose-rate (LDR) brachytherapy to high dose-rate (HDR) brachytherapy. We report clinical outcomes after brachytherapy for cervical cancer at our institution over a continuous 10-year period. METHODS AND MATERIALS:From 2004 to 2014, 258 women (184 LDR and 74 HDR) we...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.12.005

    authors： Romano KD,Pugh KJ,Trifiletti DM,Libby B,Showalter TN

    更新日期：2017-01-01 00:00:00

  • Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry.

    abstract：PURPOSE:(1) To demonstrate the feasibility of C-arm cone-beam computed tomography (CBCT)-based postplanning and subsequent adaptation of underdosed critical areas by adding remedial seeds during the transrectal ultrasound (TRUS)-guided implantation of (125)I seeds and (2) to assess the duration of this procedure. METH...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2007.08.005

    authors： Westendorp H,Hoekstra CJ,van't Riet A,Minken AW,Immerzeel JJ

    更新日期：2007-10-01 00:00:00

  • Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer.

    abstract：PURPOSE:The available data demonstrating that superiority of LDR brachytherapy (LDR-BT) boost in high-risk prostate cancer patients under represents patients with extracapsular extension (T3a) and/or seminal vesicle invasion (T3b) have been limited. We report long-term clinical outcomes data for patients with cT3a/b di...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2018.07.001

    authors： Agarwal M,Chhabra AM,Amin N,Braccioforte MH,Molitoris JK,Moran BJ

    更新日期：2018-01-01 00:00:00

  • MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy.

    abstract：PURPOSE:We sought to develop an activity nomogram for magnetic resonance (MR)-planned permanent seed prostate brachytherapy to improve quality assurance through a secondary dosimetric check. METHODS AND MATERIALS:Patients undergoing MRI-assisted radiosurgery (MARS), whereby MRI is used for preoperative planning and po...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.10.002

    authors： Hanania AN,Kudchadker RJ,Bruno TL,Tang C,Anscher MS,Frank SJ

    更新日期：2020-01-01 00:00:00

  • Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.

    abstract：PURPOSE:To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. METHODS AND MATERIALS:Between 1998 and 2009, 229 patients wer...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2012.05.003

    authors： Kotecha R,Yamada Y,Pei X,Kollmeier MA,Cox B,Cohen GN,Zaider M,Zelefsky MJ

    更新日期：2013-01-01 00:00:00

  • Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.

    abstract：PURPOSE:To evaluate the efficacy and side effect profile of adjuvant vaginal vault brachytherapy alone after hysterectomy in Stage I endometrial carcinoma. METHODS AND MATERIALS:Between 23/11/1992 and 16/05/2005, a total of 173 patients with early endometrial carcinoma treated with vaginal vault brachytherapy alone po...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.01.001

    authors： Chong I,Hoskin PJ

    更新日期：2008-04-01 00:00:00

  • Salvage low-dose-rate brachytherapy for local recurrences after prostatectomy and adjuvant or salvage external beam irradiation: Feasibility study on five patients and literature review.

    abstract：PURPOSE:To assess the feasibility and tumor outcome of re-irradiation with low-dose-rate brachytherapy for macroscopic local recurrences after radical prostatectomy (RP) followed by adjuvant or salvage external beam radiation therapy (EBRT). METHODS AND MATERIALS:Between 2011 and 2018, five men with histologically pro...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.07.001

    authors： Le Roy C,Gassa F,Rouvière O,Desmettre O,Bringeon G,Charret J,Serre AA,Pommier P

    更新日期：2021-01-01 00:00:00

  • Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation.

    abstract：PURPOSE:To assess the safety, feasibility, and efficacy of free-hand intraoperative multicatheter breast implant (FHIOMBI) and perioperative high-dose-rate brachytherapy (PHDRBT) in early breast cancer. METHODS AND MATERIALS:Patients with early breast cancer candidates for breast conservative surgery (BCS) were prospe...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.03.001

    authors： Cambeiro M,Martinez-Regueira F,Rodriguez-Spiteri N,Olartecoechea B,Insausti LP,Elizalde A,Gastearena MI,Gallego JS,Santisteban M,Aramendía JM,Aristu JJ,Moreno LA,Moreno-Jiménez M,Valtueña G,Martínez-Monge R

    更新日期：2016-07-01 00:00:00

  • Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer.

    abstract：:In 2008, the GEC ESTRO Gyn network launched the first multiinstitutional, observational, and prospective international study on MRI-guided brachytherapy in locally advanced cervical cancer patients (EMBRACE-I). EMBRACE-I was followed by EMBRACE-II from 2016 and ongoing. Among the aims of the EMBRACE studies are to ben...

    journal_title：Brachytherapy

    pub_type： 杂志文章,评审

    doi：10.1016/j.brachy.2020.08.011

    authors： Kirchheiner K,Smet S,Spampinato S,Jensen NBK,Vittrup AS,Fokdal L,Najjari-Jamal D,Westerveld HG,Lindegaard JC,Kirisits C,De Leeuw A,Schmid MP,Tan LT,Nout RA,Jürgenliemk-Schulz IM,Pötter R,Tanderup K,EMBRACE Collaborative

    更新日期：2020-01-01 00:00:00

  • Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.

    abstract：OBJECTIVE:To evaluate the feasibility and intermediate-term results of a short course of high-dose-rate (HDR) intravaginal brachytherapy only after hysterectomy. METHODS AND MATERIALS:From December 1999 to February 2005, 50 patients with International federation of gynecology and obstetrics Stages IA-IIB endometrioid ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2007.04.001

    authors： Martínez-Monge R,Nagore G,Cambeiro M,Garrán C,Villafranca E,Jurado M

    更新日期：2007-07-01 00:00:00

  • Locally advanced cervical cancer in renal transplant patients: a dilemma between control and toxicity.

    abstract：PURPOSE:Treatment of locally advanced cervical cancer in patients with a renal graft requires precautions. The graft is usually in a pelvic position, close to the clinical target volume (CTV). Preserving the graft while ensuring local control is a challenge we have faced in two occasions. We report our experience. MET...

    journal_title：Brachytherapy

    pub_type： 社论

    doi：10.1016/j.brachy.2013.11.003

    authors： Maroun P,Rivin E,Dumas I,Mondini M,Brahim J,Haie-Meder C,Mazeron R

    更新日期：2014-01-01 00:00:00

  • Bone HDR brachytherapy in a patient with recurrent Ewing's sarcoma of the acetabulum: alternative to aggressive surgery.

    abstract：:A 17-year-old girl diagnosed with a previously irradiated, locally recurrent Ewing's sarcoma involving the puboischiatic rami and the adjacent acetabulum was referred to our institution for consideration of salvage hindquarter resection. A conservative resection with implantation of the acetabular remnant for high-dos...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/S1538-4721(03)00098-9

    authors： Martínez-Monge R,Pérez-Ochoa A,San Julián M,Aquerreta D,Sierrasesúmaga L

    更新日期：2003-01-01 00:00:00

  • Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.

    abstract：PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.05.005

    authors： Vuolukka K,Auvinen P,Palmgren JE,Voutilainen T,Aaltomaa S,Kataja V

    更新日期：2019-01-01 00:00:00

  • Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer.

    abstract：PURPOSE:In this planning study, we investigated the dosimetric benefit of repeat CT-based treatment planning at each fraction vs. the use of a single CT-based treatment plan for all fractions for high-dose-rate endorectal brachytherapy (HDREBT) for rectal cancer. METHODS AND MATERIALS:We included 11 patients that rece...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.08.011

    authors： van den Ende RPJ,Rijkmans EC,Kerkhof EM,Nout RA,Ketelaars M,Laman MS,Marijnen CAM,van der Heide UA

    更新日期：2018-01-01 00:00:00

  • Monte Carlo calculation of the dose perturbations in a dual-source HDR/PDR afterloader treatment unit.

    abstract：PURPOSE:Currently, there are high dose rate afterloaders available that can drive two different radioactive sources simultaneously. The source-source and source-cable attenuations are not taken into account by current planning systems. The purpose of this work is to characterize these effects and their overall impact o...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.03.007

    authors： Collins-Fekete CA,Plamondon M,Verhaegen F,Beaulieu L

    更新日期：2016-07-01 00:00:00

  • Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy.

    abstract：PURPOSE:To analyze the effect of tungsten shields present in a Fletcher-Suit-Delclos ovoid by comparing the dose distribution computed by a treatment planning system (TPS) to the delivered dose distribution measured by radiochromic film dosimetry. METHODS AND MATERIALS:Gafchromic/EBT films were carefully wrapped aroun...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2010.08.008

    authors： Hira M,Podgorsak MB,Jaggernauth W,Malhotra HK

    更新日期：2011-05-01 00:00:00

  • Income generated by women treated with magnetic resonance imaging-based brachytherapy: A simulation study evaluating the macroeconomic benefits of implementing a high-end technology in a public sector healthcare setting.

    abstract：PURPOSE:To estimate the difference in income generated if all women presenting in our institute over a 5-year period were treated with MRI-based image-guided brachytherapy (MR-IGBT) instead of conventional radiograph-based brachytherapy (CR-BT). METHODS AND MATERIALS:Outcome data from 463 patients (94 treated with MR-...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.05.003

    authors： Chakraborty S,Mahantshetty U,Chopra S,Lewis S,Hande V,Gudi S,Krishnatry R,Engineer R,Shrivastava SK

    更新日期：2017-01-01 00:00:00

  • Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

    abstract：PURPOSE:Androgen deprivation therapy (ADT) has been shown to improve survival for men with unfavorable-risk prostate cancer (PCa). We investigated the utilization and factors associated with the omission of ADT in radiation-managed high-risk PCa. METHODS AND MATERIALS:We used the National Cancer Database to identify m...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.07.001

    authors： Chen YW,Muralidhar V,Mahal BA,Nezolosky MD,Beard CJ,Choueiri TK,Hoffman KE,Martin NE,Orio PF,Sweeney CJ,Feng FY,Trinh QD,Nguyen PL

    更新日期：2016-01-01 00:00:00

  • The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer - a benchmark for high-tech external beam radiotherapy alone?

    abstract：PURPOSE:Dose escalation using high-dose-rate brachytherapy (HDR-BT) is an established treatment method for prostate cancer. First, long-term results were previously published (specific Kiel method). This study aims to evaluate 10-/15-year outcomes of Kiel Protocol 1 (1986-1992). METHODS AND MATERIALS:Conformal externa...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2013.11.002

    authors： Galalae RM,Zakikhany NH,Geiger F,Siebert FA,Bockelmann G,Schultze J,Kimmig B

    更新日期：2014-03-01 00:00:00